Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » Twist Bioscience, Neogene Therapeutics Partner to Develop Personalized CAR T Cells, TCR Therapies

Twist Bioscience, Neogene Therapeutics Partner to Develop Personalized CAR T Cells, TCR Therapies

Oct 13, 2020
|
staff reporter

NEW YORK – Twist Bioscience and Neogene Therapeutics said on Tuesday that they have formed a broad strategic partnership to develop personalized chimeric antigen receptor (CAR) T cell therapies and T cell receptor (TCR) therapies for patients with cancer.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Even Bigger

Politico reports that the NYPD DNA database has grown since it announced it would be removing profiles from it.

Got Into the Lab Machines

Forbes reports that a structural biology lab at Oxford University studying the coronavirus was hacked.

Not Going to Pay

Science reports that a Dutch research funding agency is combating a ransomware attack.

Science Papers Present Haplotype-Resolved Genomes, MiRNA-Linked Complex Tied to Ribosomal Protein Production

In Science this week: set of 64 haplotype assemblies from 32 individuals, and more.

What's Popular?

In Business News

  1. Luminex Shares Surge on Rumor of Acquisition by DiaSorin

  2. People in the News: New Appointments at Qiagen, ImmunoScape, 908 Devices, More

  3. Genomics Firms Taking Advantage of SPACs Trend to Go Public Faster

    Premium

  4. GenMark Diagnostics Q4 Revenues Rise 84 Percent on MDx Sales

  5. 10x Genomics Acquires Denmark's Tetramer Shop

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.